Renaissance Technologies LLC Makes New Investment in Corteva, Inc. $CTVA

Renaissance Technologies LLC purchased a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 14,600 shares of the company’s stock, valued at approximately $1,222,000.

Several other large investors also recently made changes to their positions in CTVA. JPL Wealth Management LLC bought a new stake in shares of Corteva in the 3rd quarter worth approximately $25,000. Westfuller Advisors LLC grew its position in Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after buying an additional 387 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva in the fourth quarter valued at $27,000. Bank of Jackson Hole Trust acquired a new stake in shares of Corteva during the 4th quarter valued at $28,000. Finally, Cornerstone Financial Management LLC bought a new stake in shares of Corteva during the 4th quarter worth $29,000. Institutional investors own 81.54% of the company’s stock.

Get Corteva alerts:

Corteva Trading Up 0.2%

NYSE:CTVA opened at $75.71 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97. The stock’s 50-day moving average is $81.80 and its two-hundred day moving average is $80.04. The stock has a market cap of $50.51 billion, a PE ratio of 50.14, a price-to-earnings-growth ratio of 2.32 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CTVA. Royal Bank Of Canada boosted their target price on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 21st. CICC Research increased their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, Citigroup lifted their target price on shares of Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $91.70.

Check Out Our Latest Report on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

• Five stocks we like better than Corteva
• Asian Market Circuit Breakers Hit Stocks, Not AI Demand
• Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
• Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
• Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.